Growth Metrics

EBR Systems (EBRCZ) FCF Margin (2025 - 2026)

EBR Systems recorded quarterly FCF Margin of 996.66% in Q1 2026, up 43.4% quarter-over-quarter from 1760.83% in Q4 2025.

EBR Systems' FCF Margin history runs 2 years deep, the most recent figure standing at 996.66% for Q1 2026.

  • In Q1 2026, FCF Margin changed N/A year-over-year to 996.66%; the TTM figure through Mar 2026 stood at 1678.61% (changed N/A YoY), while the FY2025 annual figure was 3517.32%, changed N/A from the prior year.
  • FCF Margin came in at 996.66% for Q1 2026 at EBR Systems, up from 1760.83% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 996.66% in Q1 2026 to a low of 7286.23% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.89%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 25.51%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.29%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -1.28%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.68%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 37.67%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.98%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.44%
10 EBR Systems - - 184,000.00 -996.66%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -996.66%
Dec 31, 2025 -1,760.83%
Sep 30, 2025 -2,815.62%
Jun 30, 2025 -7,286.23%